Interprotein and SPERA PHARMA enter into an agreement for comprehensive collaboration in small molecule and peptide drug R&D

Osaka (Japan), February 16, 2022 – Interprotein Corporation and SPERA PHARMA, Inc. today hereby announce that we have signed an agreement for comprehensive collaboration aiming at research & development, m...

READ MORE